AT285619B - Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine - Google Patents

Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine

Info

Publication number
AT285619B
AT285619B AT293569A AT293569A AT285619B AT 285619 B AT285619 B AT 285619B AT 293569 A AT293569 A AT 293569A AT 293569 A AT293569 A AT 293569A AT 285619 B AT285619 B AT 285619B
Authority
AT
Austria
Prior art keywords
sydnonimines
halo
amino
preparation
new substituted
Prior art date
Application number
AT293569A
Other languages
German (de)
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of AT285619B publication Critical patent/AT285619B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT293569A 1968-03-26 1969-03-25 Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine AT285619B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (1)

Publication Number Publication Date
AT285619B true AT285619B (de) 1970-11-10

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT293569A AT285619B (de) 1968-03-26 1969-03-25 Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine

Country Status (18)

Country Link
AT (1) AT285619B (es)
BE (1) BE730510A (es)
BG (1) BG15220A3 (es)
BR (1) BR6907417D0 (es)
CA (1) CA945990A (es)
CH (1) CH519511A (es)
DE (1) DE1770061A1 (es)
DK (1) DK130296B (es)
ES (2) ES364979A1 (es)
FI (1) FI54480C (es)
FR (1) FR2004770A1 (es)
GB (1) GB1219254A (es)
HU (1) HU162735B (es)
IE (1) IE32708B1 (es)
IL (1) IL31909A (es)
NL (1) NL6904632A (es)
SE (1) SE374746B (es)
YU (1) YU69369A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
NL6904632A (es) 1969-09-30
GB1219254A (en) 1971-01-13
DK130296B (da) 1975-02-03
CH519511A (de) 1972-02-29
DE1770061A1 (de) 1971-09-16
IL31909A (en) 1973-01-30
CA945990A (en) 1974-04-23
HU162735B (es) 1973-04-28
BR6907417D0 (pt) 1973-04-12
FI54480B (fi) 1978-08-31
IE32708B1 (en) 1973-10-31
YU69369A (en) 1978-09-18
FR2004770A1 (es) 1969-11-28
SE374746B (es) 1975-03-17
IE32708L (en) 1969-09-26
DK130296C (es) 1975-06-30
ES364979A1 (es) 1971-02-16
IL31909A0 (en) 1969-05-28
ES376981A1 (es) 1972-05-01
BE730510A (es) 1969-09-26
BG15220A3 (bg) 1975-11-21
FI54480C (fi) 1978-12-11

Similar Documents

Publication Publication Date Title
CH516512A (de) Verfahren zur Herstellung neuer substituierter 1-Phenoxy-2-aminopropane
CH551412A (de) Verfahren zur herstellung neuer n-phenylindolin-derivate.
CH511856A (de) Verfahren zur Herstellung neuer trisubstituierter 2-Aryl-aminoimidazoline
CH516508A (de) Verfahren zur Herstellung neuer substituierter Hydroxyphenylalkylamine
AT289776B (de) Verfahren zur Herstellung neuer 1-Carbamoyl-3-aroylpyrrolidine
CH530988A (de) Verfahren zur Herstellung neuer Diallylaminoalkanoylamide
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
AT299916B (de) Verfahren zur Herstellung neuer bis-Aminobenzoate
CH516591A (de) Verfahren zur Herstellung neuer Thiazolopyrrolopyrimidine
CH496719A (de) Verfahren zur Herstellung neuer Pyrrolopyrimidin-Derivate
AT305253B (de) Verfahren zur Herstellung neuer Diphenoxyacetamide
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
AT297017B (de) Verfahren zur Herstellung neuer O-Halogenphenylcarbamate
AT292692B (de) Verfahren zur Herstellung neuer Nitroimidazolverbindungen
CH528513A (de) Verfahren zur Herstellung neuer substituierter Triazenopyrazole
CH471077A (de) Verfahren zur Herstellung neuer substituierter Aryloxy-2-hydroxy-3-aminopropane
AT319914B (de) Verfahren zur Herstellung neuer Triazapentadiene
CH513131A (de) Verfahren zur Herstellung neuer Aminobenzocycloalkylnitrile
CH536825A (de) Verfahren zur Herstellung neuer 18-Methyl-5a-H- -androstane
AT285619B (de) Verfahren zur Herstellung neuer substituierter 3-Amino-4-halogen-sydnonimine
AT295515B (de) Verfahren zur Herstellung neuer 3,5-Dioxo-pyrazolidine
CH532612A (de) Verfahren zur Herstellung neuer a-Azidobenzylpenicilline
CH511227A (de) Verfahren zur Herstellung neuer Azetidinolderivate
CH521352A (de) Verfahren zur Herstellung neuer Sulfonylaminopyrimidine
CH519505A (de) Verfahren zur Herstellung neuer Sulfonylaminopyrimidine

Legal Events

Date Code Title Description
ELA Expired due to lapse of time